ArticleHematological oncology2025

Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.

Anna Sureda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.